by IR Team | Sep 16, 2020 | News
San Diego-based Axim Biotechnologies Inc., an international health care solutions company targeting oncological and COVID-19 research, has filed an emergency use authorization (EUA) application with the U.S. FDA for measuring COVID-19 neutralizing antibodies in plasma...
by IR Team | Jul 23, 2020 | News
By Microcap Daily Axim Biotechnologies Inc (OTCMKTS: AXIM) is making a big move to the upside after the Company announced strong results for its Rapid NeuCovix™ test which was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum...
by IR Team | Jul 23, 2020 | News
By Baystreet The old adage, “he also serves who only sits and waits,” is being severely tested these days with the impatience millions are feeling to see some sort of banishment of the deadly COVID-19. Thomas Edison’s statement “he also serves who hustles...
by IR Team | Jul 22, 2020 | News
By Verdict Medical Devices Medical Marijuana has announced that its investment company AXIM Biotechnologies has developed a rapid diagnostic test that measures the levels of functional neutralising antibodies that are said to prevent SARS-CoV-2 (Covid-19) infection....
by IR Team | Jul 16, 2020 | News
By LabMedica.com A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for vaccine developers around the world as they begin...
by IR Team | Jul 16, 2020 | News
By Medical Laboratory Observer AXIM Biotechnologies, an healthcare solutions company focused on oncological research, has announced the development of NeuCovix, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent...
